1. Home
  2. DSX vs AARD Comparison

DSX vs AARD Comparison

Compare DSX & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

N/A

Current Price

$2.48

Market Cap

276.7M

ML Signal

N/A

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

N/A

Current Price

$3.80

Market Cap

281.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSX
AARD
Founded
1999
2017
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.7M
281.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSX
AARD
Price
$2.48
$3.80
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$19.63
AVG Volume (30 Days)
931.3K
447.4K
Earning Date
02-26-2026
05-13-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.28
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$4.06
52 Week High
$2.72
$17.94

Technical Indicators

Market Signals
Indicator
DSX
AARD
Relative Strength Index (RSI) 54.54 19.79
Support Level $2.26 N/A
Resistance Level $2.72 $6.19
Average True Range (ATR) 0.13 0.45
MACD -0.01 -0.00
Stochastic Oscillator 54.32 2.94

Price Performance

Historical Comparison
DSX
AARD

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: